Canadian Journal of Infectious Diseases and Medical Microbiology

Table of Contents: 1992

  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 510914

BRM Immunotherapy of Orthotopically Implanted Murine Bladder Tumours: Treatment Response by Monitoring MRI

Salam A Kadhim | Joseph L Chin | ... | Stephen J Karlik
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 652358
  • - Case Report

De Novo Subgaleal Abscess

JP Schaefer | LJ Clein | JM Conly
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 917546

AM3, an Oral BRM: Protective Agent against Iatrogenic Bone-Marrow and Liver Damage in Breast Cancer Patients under Conventional Adjuvant Radiochemotherapy

Vicente G Villarrubia | Paula Marquez | ... | Guillermo J Sada
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 342127

Continuous Indomethacin and Ranitidine with Interleukin-2 in Advanced Renal Carcinoma and Melanoma: A Preliminary Report

Wilson C Mertens | Vivien HC Bramwell | ... | Walter Romano
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 754560

Interferons: Antiangiogenesis Agents (A Reasonable Theory)

Joseph G Sinkovics
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 234936

Preclinical Evaluation of a Bone-Marrow Autograft Culture Procedure for Generating Lymphokine-Activated Killer Cells in Vitro

Hans-Georg Klingemann | Heather Deal | ... | Connie J Eaves
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 460394

Interferon-gamma: A Potent Antiviral Agent Targeting Macrophages Infected with LP-BM5 Murine Leukemia Virus, the Causative Agent of 'AIDS' in Mice

Jens J Kort | Julie L Eiseman
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 875050

Involvement of Cytokines in the Pathogenesis of Hypersensitivity Pneumonitis: Evaluation of Immunotherapeutic Measures in a Mouse Model

Michel Denis | Marie Bédard | ... | Michel Laviolette
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 181709

Hypoxanthine Derivatives in Experimental Infections

Claudio De Simone | Edoardo Arrigoni Martelli | ... | Giorgio Tonietti
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 398178

Conjugation of Daunorubicin to Monoclonal Antihuman Sarcoma Antibody by a Novel Method

Michel Pagé | Denis Thibeault | ... | Marie-Josée Perron
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 591894

SDZ MRL 953, A Novel Synthetic Lipid a Analogue, Induces Tolerance to the Lethal Effects of Endotoxin and Enhances Nonspecific Immunity

Charles Lam | Eberhard Schütze | ... | Peter Stütz
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 342364

Adjuvants for a New Generation of Vaccines

Anthony C Allison | Noelene E Byars
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 710476
  • - Brief Report

Antibody to Hepatitis C Virus in Risk Groups in Canada

RK Chaudhary | Theresa Mo
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 480430

Potential Manipulations to Restore Aberrant Myelopoiesis: The Role of New Colony-Stimulating Factors and other Agents

James J Rusthoven
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 942680

Insights into Normal Myelopoiesis

Dennis G Osmond
Canadian Journal of Infectious Diseases and Medical Microbiology
 Journal metrics
See full report
Acceptance rate13%
Submission to final decision109 days
Acceptance to publication14 days
CiteScore3.700
Journal Citation Indicator0.480
Impact Factor2.8
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.